{
  "text": "Carbamazepine-induced antinuclear antibodies and systemic lupus erythematosus-like syndrome.\n A 20-year-old woman developed a systemic lupus erythematosus (SLE)-like syndrome and a positive antinuclear antibody (ANA) soon after initiation of carbamazepine (CBZ) therapy.\n Symptoms and serology became normal after CBZ was discontinued.\n CBZ-induced SLE is an important but underecognized phenomenon.",
  "category": "C20"
}